Related Experiment Video
Updated: Jan 9, 2026

Detection of Post-Replicative Gaps Accumulation and Repair in Human Cells Using the DNA Fiber Assay
Published on: February 3, 2022
EP300 deficiency leads to chronic replication stress mediated by defective replication fork protection
Angelica Barreto-Galvez1, Mrunmai Niljikar1, Julia Elizabeth Gagliardi1
1Rutgers Cancer Institute of New Jersey, New Brunswick, NJ, USA.
Abstract:
Mutations in the global transcriptional activator EP300/KAT3B are being reported in aggressive malignancies. However, the mechanistic contribution of EP300 dysregulation to cancer is currently unknown. While EP300 has been implicated in regulating cell cycle and DNA replication, the role of EP300 in maintaining replication fork integrity has not been studied. Here, using EP300-mutated adult T-cell leukemia/lymphoma cells and an EP300-selective degrader, we reveal that EP300 loss leads to pronounced dysregulations in DNA replication dynamics and persistent genomic instability. Aberrant DNA replication in EP300-mutated cells is characterized by elevated replication origin firing due to replisome pausing. EP300 deficiency results in a prominent defect in fork protection resulting in the accumulation of single-stranded DNA gaps. Importantly, we find that the loss of EP300 results in decreased expression of BRCA2 protein leading to sensitivity to treatments that are cytotoxic to BRCA-deficient cancers. Overall, we demonstrate that EP300-mutated cells recapitulate features of BRCA-deficient cancers.
Insights
Loss of EP300 (also known as KAT3B) in cancer cells disrupts DNA replication, causing genomic instability and sensitivity to BRCA-deficient cancer treatments. This highlights EP300
Area of Science:
- Molecular Biology
- Cancer Genomics
- DNA Replication
Background:
- Mutations in EP300/KAT3B are linked to aggressive cancers, but the underlying mechanisms remain unclear.
- EP300 is known to regulate cell cycle and DNA replication, yet its role in maintaining replication fork integrity is unstudied.
Purpose of the Study:
- To investigate the mechanistic contribution of EP300 dysregulation to cancer.
- To explore the role of EP300 in maintaining DNA replication fork integrity and its impact on genomic stability.
Main Methods:
- Utilized EP300-mutated adult T-cell leukemia/lymphoma cell lines.
- Employed an EP300-selective degrader to study the effects of EP300 loss.
- Analyzed DNA replication dynamics, replisome pausing, fork protection, and single-stranded DNA gap accumulation.
Main Results:
- EP300 loss induces significant dysregulation in DNA replication dynamics and persistent genomic instability.
- Cells exhibit aberrant DNA replication with increased origin firing due to replisome pausing and impaired fork protection.
- EP300 deficiency leads to decreased BRCA2 expression, conferring sensitivity to treatments targeting BRCA-deficient cancers.
Conclusions:
- EP300 loss disrupts DNA replication fork integrity, leading to genomic instability in cancer cells.
- EP300-mutated cells exhibit characteristics similar to BRCA-deficient cancers, including sensitivity to specific therapies.
- This study reveals EP300 as a critical factor in maintaining genomic stability and suggests therapeutic vulnerabilities in EP300-mutated malignancies.
Related Concept Videos
Restarting Stalled Replication Forks
The DNA Replication Fork
The DNA Replication Fork
DNA Damage can Stall the Cell Cycle
DNA Damage Can Stall the Cell Cycle
Replication in Eukaryotes
Many Proteins Orchestrate Replication at the Origin
Eukaryotic replication follows many of the same...

